| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 249.164 | 230.418 | 232.722 | 245.379 | 236.498 | 228.513 | 9.202 | 0 | 0 | 0 |
| Total Income - EUR | 255.926 | 234.575 | 237.796 | 249.426 | 237.723 | 277.711 | 9.583 | 59 | 1 | 1 |
| Total Expenses - EUR | 262.513 | 239.425 | 239.247 | 252.053 | 242.041 | 228.731 | 26.289 | 15.258 | 6.066 | 3.555 |
| Gross Profit/Loss - EUR | -6.587 | -4.850 | -1.452 | -2.627 | -4.318 | 48.980 | -16.706 | -15.199 | -6.064 | -3.554 |
| Net Profit/Loss - EUR | -6.587 | -4.850 | -3.623 | -5.122 | -6.695 | 46.379 | -16.802 | -15.201 | -6.064 | -3.554 |
| Employees | 4 | 4 | 4 | 3 | 3 | 3 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Regal Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 207 | 153 | 682 | 516 | 356 | 250 | 146 | 0 | 0 | 0 |
| Current Assets | 81.979 | 72.952 | 68.974 | 70.297 | 56.582 | 95.776 | 29.887 | 14.762 | 8.651 | 5.049 |
| Inventories | 14.487 | 9.730 | 7.852 | 9.563 | 8.581 | 7.784 | 0 | 0 | 0 | 0 |
| Receivables | 55.482 | 51.226 | 55.001 | 53.071 | 41.623 | 65.278 | 15.387 | 4.391 | 4.709 | 3.756 |
| Cash | 12.010 | 11.997 | 6.120 | 7.664 | 6.378 | 22.714 | 14.500 | 10.371 | 3.942 | 1.293 |
| Shareholders Funds | 16.644 | 11.624 | 7.805 | 2.540 | -4.204 | 42.255 | 24.516 | 9.391 | 3.298 | -275 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 65.541 | 61.481 | 61.850 | 68.273 | 61.142 | 53.770 | 5.518 | 5.372 | 5.353 | 5.324 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharma Regal Srl